Speer’s report is the latest in a new series of MLI papers examining the federal role in Canadian health care delivery and funding. The series has demonstrated that Ottawa’s role in health care has traditionally been marked by a caution that recognizes the primacy of the provinces and territories in health care delivery and administration. In fact, progress tends to be correlated with a more restricted federal involvement.
Even so, the paper, titled “Structure and Design: Why More Funding is Not Necessarily Better for Health and Medical Research,” reminds us that some health-related policy areas do fit naturally as a federal responsibility – specifically, funding health research through the Canadian Institutes of Health Research (CIHR).
As Speer notes, federal funding for CIHR and other health-related research organizations, such as Genome Canada, Brain Canada, and others, is broadly seen as a “public good that market forces alone cannot address.” The federal government can help support health research and innovation by both ensuring a strong patent regime, which MLI has written extensively in favour of, and through direct funding research.
But Ottawa needs to place as much care with the “design and structure” of health and medical funding as ensuring sufficient levels of funding. Lessons can be found in the US, where a significant infusion of funding followed by more modest growth had – according to former White House health policy advisor Yuval Levin – actually hurt medical research. The unintended result was to create “unsustainable pressures on the part of research institutions” once that significant funding infusion had run its course.
A similar problem can be found with CIHR, when a significant increase in funding between 2000-2005 was followed by a slowing in funding growth, and significant concerns and criticism by the research community.
More analysis is needed to properly assess the problem and its effects on health research in Canada. But immediate steps can be taken to improve our “design and structure” – specifically, by setting out a strategic, long-term vision for the CIHR and providing for stable, predicable funding growth over a 10-year period. In so doing, the federal government could work to establish a better structure and design for promoting and supporting health and medical research in Canada.
To learn more about health and medical research funding in Canada, check out our latest commentary here.
Sean Speer is a Munk Senior Fellow at the Macdonald-Laurier Institute. He previously served in different roles for the federal government including as senior economic advisor to the Prime Minister and director of policy to the Minister of Finance.
For more information please contact:
Communications and Digital Media Manager